Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL630577 | 0.79 | TDP1 (0.48) | CPB1TDP1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL13017108 | 0.72 | FOLH1 (0.45) | CPB1TDP1SMN1; SMN2PGD | |
| SCHEMBL12534931 | 0.71 | SLC22A6 (0.36) | TDP1SMN1; SMN2PGD | |
| SCHEMBL12534908 | 0.71 | SLC22A6 (0.36) | TDP1SMN1; SMN2PGD | |
| SCHEMBL12221575 | 0.71 | TDP1 (0.58) | TDP1SMN1; SMN2PGD | |
| SCHEMBL13772960 | 0.70 | POLB (0.39) | CPB1TDP1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL15314812 | 0.70 | SLC22A6 (0.52) | TDP1SMN1; SMN2PGD | |
| SCHEMBL17853917 | 0.69 | CPB1 (0.38) | CPB1ALDH1A1POLBSMN1; SMN2CYP2C19 | |
| SCHEMBL12602997 | 0.68 | PGD (0.35) | TDP1SMN1; SMN2PGD | |
| SCHEMBL13555640 | 0.68 | SRC (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9834509-B2 | Metal-catalyzed oxidative coupling of thiols | ECOLAB USA INC. (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170036998-A1 | Metal-Catalyzed Oxidative Coupling of Thiols | ECOLAB USA INC. (US) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170036998-A1 | Metal-Catalyzed Oxidative Coupling of Thiols | TST, SOD1, PRDX3 | CPB1 2982/4885TDP1 3685/4885ALDH1A1 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.